Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2005. Start Trial.
Date Value
November 17, 2026 2.366B
November 16, 2026 2.366B
November 13, 2026 2.366B
November 12, 2026 2.366B
November 11, 2026 2.366B
November 10, 2026 2.366B
November 09, 2026 2.366B
November 06, 2026 2.276B
November 05, 2026 2.276B
November 04, 2026 2.276B
November 03, 2026 2.276B
November 02, 2026 2.276B
October 30, 2026 2.276B
October 29, 2026 2.276B
October 28, 2026 2.276B
October 27, 2026 2.276B
October 26, 2026 2.276B
October 23, 2026 2.276B
October 22, 2026 2.276B
October 21, 2026 2.276B
October 20, 2026 2.276B
October 19, 2026 2.276B
October 16, 2026 2.276B
October 15, 2026 2.276B
October 14, 2026 2.276B
Date Value
October 13, 2026 2.276B
October 12, 2026 2.276B
October 09, 2026 2.276B
October 08, 2026 2.276B
October 07, 2026 2.096B
October 06, 2026 2.095B
October 05, 2026 2.095B
October 02, 2026 2.095B
October 01, 2026 2.095B
September 30, 2026 2.095B
September 29, 2026 2.216B
September 28, 2026 2.134B
September 25, 2026 2.134B
September 24, 2026 2.134B
September 23, 2026 2.134B
September 22, 2026 2.134B
September 21, 2026 2.134B
September 18, 2026 2.134B
September 17, 2026 2.134B
September 16, 2026 2.134B
September 15, 2026 2.134B
September 14, 2026 2.134B
September 11, 2026 2.134B
September 10, 2026 2.134B
September 09, 2026 2.134B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Evaxion AS 16.29M
Genmab A/S 35.29B
Ascendis Pharma A/S 17.20B
Zealand Pharma A/S 436.42M
Agenus, Inc. 464.42M